PF-Atlas › Clinical Trials › NCT02227888
PK Study of N91115 in Cystic Fibrosis Patients
N91115 · Phase 1
Registry ID
NCT02227888
Phase
Phase 1
Status
Completed
Drug / intervention
N91115
Sponsor
Nivalis Therapeutics, Inc.
Start
2014-10
About this trial
N91115 is evaluated in NCT02227888, a Phase 1 idiopathic pulmonary fibrosis study sponsored by Nivalis Therapeutics, Inc.. Current status: Completed.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT02227888 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.